COM:ALIMERASCIENCES
Alimera Sciences Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Pharmaceuticalswebsite
alimerasciences.com/ipo date
Nov 04, 2019
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindnes...Show More